PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#1504 ×

UPDATED
Regulatory Updates
Aug 28, 2026•1 min read
FDA Updates LOESTRIN 21 1.5/30 (NDA 017875) Submissions
FDA records show multiple labeling and manufacturing submissions for LOESTRIN 21 1.5/30, a discontinued oral contraceptive tablet, with the latest activity in May 2022.